Axio BioPharma Raises $2.4 Million to Connect Manufacturing Data Across Companies
Funding will support initial Axio Lattice deployments connecting pharma with their manufacturing partners
The latest from Axio
All posts
7 POSTS-
Axio BioPharma Selected for Plug and Play Lifetech Accelerator’s Third Cohort
Program participation will support industry engagement around Axio’s data infrastructure and execution capabilities for biologics development and manufacturing
-
Axio BioPharma Selects Ansa Biotechnologies as Preferred Gene Synthesis Provider
Preferred partnership helps strengthen high-throughput antibody production workflows by reducing schedule risk and improving delivery predictability
-
Axio BioPharma and The Bioforge Partner to Unlock Historical Biomanufacturing Data for AI-Driven Process Optimization
Partnership pairs Axio Lattice with BioOptima AI™ to unlock historical process knowledge while preserving data ownership
-
Axio BioPharma Releases New Industry Report on the Future of AI-Enabled Biomanufacturing
MADISON, Wis., May 13, 2026 — Axio BioPharma today announced the launch of its new industry eBook, “AI in Biomanufacturing: How Operating Models, Digital Twins, and Federated Intel…
-
Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin
Madison, WI (February 3, 2026) — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1…
-
Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing
MADISON, Wis., June 16, 2025 -- Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, today announced the continued ex…
Get the next update in your inbox
Occasional notes on biologics, AI-driven process development, and what the team is building. No marketing fluff.
Tell us what your program needs to share with another company
Use your message to explain which teams need to share information and what makes that difficult.